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 Background: Accelerated high frequency repetitive transcranial magnetic stimulation 
(aHF-rTMS) has proven to produce fast clinical effects in humans suffering from psychiatric 
illnesses. Although dogs also frequently present behavioural symptoms similar to mental 
illness, nothing is known about the clinical influence in this species. A 5-year-old neutered 
male Belgian shepherd dog was presented with anxious aggressive behaviour.  
 Hypothesis: It was hypothesized that an aHF-rTMS treatment over the frontal cortex 
would improve the dogs’ behaviour and alter its regional cerebral blood flow (rCBF) and 
monoamines.  
Methodology: An aHF-rTMS protocol was applied twice (3 weeks separated) over the 
left frontal cortex (5 sessions, 20Hz, 110% CMT). Each protocol was preceded and followed 
by a behaviour assessment and a [99mTc]HMPAO-SPECT scan. A Z-score for each VOI at 
each time point was obtained, a |Z|-score > 3.09 (P-value of 0.001) indicated significant 
differences. Cerebrospinal fluid (CSF) and serum was analysed for the detection of 
monoamines.  
Results: An improvement of the dogs’ aggressive behaviour was detected. At 
baseline, only a decreased rCBF of the left frontal cortex was noticeable (Z-score = -3.87). 
Twenty-four hours after the first protocol, the perfusion in the left frontal cortex was 
normalized but decreased in subcortical region (Z-score = -6.97). Twenty-four hours after the 
second protocol, only the subcortical region was hypo-perfused (Z-score = -6.88). Three 
weeks after each stimulation protocol, no deviations in the rCBF were found. Parallel changes 
(over time) of 3,4-Dihydroxyphenylacetic acid (DOPAC) concentrations in the serum and 
CSF were present (table 1). 
 Conclusion: This case study demonstrates that a single day aHF-rTMS treatment 
reduces a dogs' anxious/aggressive behaviour. This was accompanied by immediate and long-
lasting alterations in the rCBF and DOPAC concentration. Thereby, this study confirms the 
interaction between the frontal cortex and the subcortical region in behaviour in dogs and puts 
DOPAC forward as possible biomarker. 
 
 Monoamines Baseline  1
st protocol 
24 hours 
1st protocol 
3 weeks 
2nd protocol 
24 hours 
2nd protocol 
3 weeks 
 Serum         
NAD 3.62 4.55 4.16 4.01 6.23 
AD 11.50 8.81 14,20 10.31 26.96 
DA Na Na Na Na Na 
DOPAC 26.39 122.41 33.067 92.76 27.90 
HVA 30.63 42.86 24.72 24.69 29.79 
5-HT 21.59 18.62 29.97 25.23 25.17 
5-HIAA Na Na Na Na Na 
CSF      
NAD 1.45 1.63 1.54 1.23 Na 
AD 2.00 1.99 2.06 1.93 Na 
DA Na Na Na Na Na 
DOPAC 0.16 0.49 0.25 0.87 Na 
HVA 12.57 19.40 12.70 11.31 Na 
5-HT Na Na Na Na Na 
5-HIAA 2.20 3.70 2.35 2.49 Na 
Table	1:	Concentrations	(ng/100	µl)	of	7	monoamines	measured	with	HPLC.	NAD		=	Norepinephrine;	AD	=	Epinephrine;	
DOPAC	=	3,4-Dihydroxyphenylacetic	acid;	HVA	=	Homovanillic	acid;	5-HT	=	Serotonin;	5-HIAA	=	5-Hydroxyindoleacetic	
acid;	Na	=	missing	data.	
